AYTU BIOPHARMA, INC Retained Earnings
AYTU BIOPHARMA, INC (AYTU) had Retained Earnings of -$347.79 million as of 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-09-22
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$347.79M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$347.77M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$342.15M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$331.57M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$347.79M 10-K · filed 2026-09-22 | |
| 2026-03-31 | -$347.77M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | -$342.15M 10-Q · filed 2026-02-03 | |
| 2025-09-30 | -$331.57M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$333.54M 10-K · filed 2026-09-22 | |
| 2025-03-31 | -$313.72M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | -$317.71M 10-Q · filed 2025-02-12 | |
| 2024-09-30 | -$318.50M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | -$319.97M 10-K · filed 2025-09-23 | |
| 2024-03-31 | -$315.36M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | -$312.47M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | -$312.25M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$304.13M 10-K · filed 2024-09-26 | |
| 2023-03-31 | -$301.67M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$294.47M 10-Q · filed 2023-02-21 | |
| 2022-09-30 | -$287.78M 10-Q/A · filed 2023-02-21 | -$291.35M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$287.08M 10-K · filed 2023-10-12 | -$288.47M 10-K · filed 2022-09-27 |
| 2022-03-31 | -$270.99M 10-Q · filed 2023-05-11 | -$270.77M 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$217.70M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | -$206.15M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$178.30M 10-K · filed 2022-09-27 | |
| 2021-03-31 | -$159.30M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | -$133.84M 10-Q · filed 2021-02-11 | |
| 2020-09-30 | -$124.32M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | -$120.01M 10-K · filed 2021-09-28 | -$120.01M 10-K · filed 2020-10-06 |
| 2020-03-31 | -$116.87M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | -$111.53M 10-Q · filed 2020-02-14 | |
| 2019-09-30 | -$111.32M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | -$106.39M 10-K · filed 2020-10-06 | |
| 2019-03-31 | -$91.86M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | -$87.36M 10-Q · filed 2019-05-14 | |
| 2018-09-30 | -$82.70M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | -$79.26M 10-K · filed 2019-09-26 | |
| 2018-03-31 | -$79.81M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | -$76.99M 10-Q · filed 2018-02-08 | |
| 2017-09-30 | -$73.31M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | -$69.07M 10-K · filed 2018-09-06 | |
| 2017-03-31 | -$62.32M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | -$57.10M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | -$52.29M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | -$46.56M 10-K · filed 2017-08-31 | |
| 2016-03-31 | -$31.26M 10-Q · filed 2016-05-11 | |
| 2015-12-31 | -$23.99M 10-Q · filed 2016-02-11 | |
| 2015-09-30 | -$20.66M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | -$18.38M 10-K · filed 2016-09-01 | |
| 2015-03-31 | -$12.61M 10-Q · filed 2015-05-19 | |
| 2015-02-28 | -$656.06K 10-Q · filed 2015-04-15 | |
| 2014-11-30 | -$646.18K 10-Q · filed 2015-01-12 | |
| 2014-08-31 | -$630.43K 10-Q · filed 2015-04-15 | |
| 2014-06-30 | -$10.66M 10-K · filed 2015-09-28 | -$7.04M 10-Q · filed 2015-05-19 |
| 2014-05-31 | -$500.00 10-Q · filed 2014-07-10 | |
| 2014-02-28 | -$500.00 10-Q · filed 2014-04-11 | |
| 2013-11-30 | -$500.00 10-Q · filed 2014-01-10 | |
| 2013-08-31 | -$500.00 10-K · filed 2014-11-26 | |
| 2013-05-31 | -$500.00 10-Q · filed 2013-06-28 | |
| 2013-02-28 | -$500.00 10-Q · filed 2013-04-15 | |
| 2012-11-30 | -$500.00 10-Q · filed 2013-01-14 | |
| 2012-08-31 | -$500.00 10-K · filed 2014-11-26 | |
| 2012-05-31 | -$500.00 10-Q · filed 2012-06-26 | |
| 2012-02-29 | -$500.00 10-Q · filed 2012-04-12 | |
| 2011-11-30 | -$500.00 10-Q · filed 2011-12-23 | |
| 2011-08-31 | -$500.00 10-K · filed 2012-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |